MYC and neoplasm: The tumor-bearing mice treated with the c-MYC drugs (3.6 μg) show a significant reduction in the tumor volume (*p = 0.019) compared to the controls (Figures 2B,C), with a tumor volume reduction of approximately half (Figure 2B).